Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine as an adjuvant to ropivacaine in scalp block for post-craniotomy pain
ChiCTR2000041363Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in postoperative pain (2 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University. Primary endpoints: Visual Analogue Scale (VAS) for pain, Blood pressure and 2 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000041363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041363.